Stay updated on ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page.

Latest updates to the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedThe page's Revision tag has been updated from v3.6.4 to v3.6.5, indicating a newer build of the page. This is a metadata update and does not change the study information shown.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe page's revision label changed from v3.6.3 to v3.6.4, indicating a minor maintenance update to the page. This does not reflect a substantive change to study details or content.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedAdded a publication citation (Horinouchi et al.) to the study Publications section describing a phase Ib study of telisotuzumab vedotin with osimertinib in c-Met–expressing NSCLC, and updated the revision tag from v3.6.2 to v3.6.3.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page footer now shows Revision: v3.6.2, replacing the previous v3.6.0. This reflects a recent site version update.SummaryDifference0.0%

- Check59 days agoChange DetectedNew user-help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting was updated. The page now includes the recruitment status note 'No longer looking for participants' and records Revision: v3.6.0.SummaryDifference0.3%

- Check67 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a minor site/software update rather than a change to study data. No changes to the study details, locations, or eligibility information are implied by this revision.SummaryDifference0.0%

Stay in the know with updates to ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABBV-399 Safety, PK, Preliminary Efficacy in Solid Tumors Clinical Trial page.